German Telecom Services and Carriers Stock News

Bayerische Motoren Werke (XTRA:BMW) is back in focus after executives outlined progress on reducing research and production costs for its Neue Klasse electric vehicle platform, supported by strong iX3 order intake and added capacity in Hungary. See our latest analysis for Bayerische Motoren Werke. The latest update on Neue Klasse comes after a weaker first quarter, where sales of €21,170 million and net income of €1,622 million were below the prior year. A year-to-date share price return that...

Why Siemens (XTRA:SIE) is back in focus after its latest earnings Siemens (XTRA:SIE) is back on many watchlists after reporting higher orders and revenue, highlighting strong demand in its Smart Infrastructure segment and unveiling a new €6b multi year share buyback program. See our latest analysis for Siemens. Despite the latest earnings beat and new buyback announcement, Siemens’ share price fell 5.15% on the day to €259.6. However, its 30 day share price return of 9.35% and 1 year total...

First quarter earnings put Hugo Boss stock in focus Hugo Boss (XTRA:BOSS) moved onto investors’ radar after first quarter 2026 results showed sales of €905 million, compared with €999 million a year earlier, and net income of €17 million, compared with €35 million. See our latest analysis for Hugo Boss. The earnings release landed against a share price of €36.01, with the stock showing a 1-day share price return of 1.27% but a 1-year total shareholder return that declined 10.29%, so near term...

Investors in SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) had a good week, as its shares rose 4.9% to close at €16.38...

Dermapharm Holding (XTRA:DMP) just reported first quarter 2026 results, with sales of €309.1 million, net income of €45.2 million and earnings per share of €0.84 from continuing operations. See our latest analysis for Dermapharm Holding. The strong Q1 release, including higher revenue, net income and reaffirmed guidance, has coincided with a clear upswing in momentum, with a 40.38% 90 day share price return and a 55.95% 1 year total shareholder return from Dermapharm Holding. If this earnings...

Shareholders of Dermapharm Holding SE ( ETR:DMP ) will be pleased this week, given that the stock price is up 12% to...

Wondering whether Mercedes-Benz Group stock is attractively priced or just looks cheap at first glance? This breakdown focuses squarely on what you are getting for the current share price. The stock last closed at €50.35, with a mixed return profile that includes a 0.4% gain over the past week, a decline of 7.5% over the past month and a 2.6% gain over the past year. Recent headlines around Mercedes-Benz Group have focused on ongoing execution in its core premium vehicles business and the...

Enapter AG ( FRA:H2O ) is possibly approaching a major achievement in its business, so we would like to shine some...

E.ON (XTRA:EOAN) opened Q1 2026 earnings season with Q4 2025 revenue of about €22.0b and basic EPS of €0.31, setting a clear marker for how its €17.87 share price sits against the latest figures. Over recent quarters, revenue has ranged from €16.3b to €25.5b while basic EPS has swung between €0.20, €0.17 and a small loss of €0.02, giving investors a broad view of how earnings power has shifted since early 2025. With trailing net profit margins at 2.2% versus 5.5% a year earlier and a sizeable...

Borussia Dortmund GmbH Kommanditgesellschaft auf Aktien (XTRA:BVB) has just posted its latest quarterly figures, with Q2 2026 revenue at €141.4 million and a basic EPS loss of €0.04, set against trailing 12 month revenue of €598.5 million and EPS of €0.16 that reflect the recent move back into profit. Over the past few reported quarters, revenue has moved between €126.7 million and €161.4 million while basic EPS has swung from a loss of €0.05 in Q4 2025 to a profit of €0.21 in Q1 2026. This...

Allianz (XTRA:ALV) opened 2026 with Q1 revenue of €28.8b and net income of €3.7b, translating into basic EPS of €9.71 as the insurer extended a run of solid trailing earnings that show 12 month basic EPS at €31.12 on revenue of €115.5b and net income of €11.9b. Over the past year, revenue has moved from €110.4b to €115.5b while basic EPS has shifted from €25.20 to €31.12, giving you a clear picture of how the top line and per share earnings have tracked together. With net profit margins...

Bayer (XTRA:BAYN) announced a major alliance with bp to commercialize camelina as a renewable fuel feedstock. The company reported positive Phase III results for its investigational cardiac amyloidosis diagnostic imaging agent. Both updates relate to Bayer’s agriculture and radiology activities and have not been covered in recent Simply Wall St articles. Bayer operates across pharmaceuticals, consumer health and crop science, and these two announcements touch both its agricultural and...

RENK Group (XTRA:R3NK) is back in focus after confirming 2026 revenue guidance above €1.5b alongside its first quarter results, which showed sales of €283.61 million and net income of €15.35 million. See our latest analysis for RENK Group. Despite confirming revenue guidance above €1.5b, RENK Group’s recent momentum has softened, with the share price at €45.11, the 30 day share price return down 13.35%, and the 1 year total shareholder return down 18.41%. If you are weighing RENK Group’s...

Siemens Energy AG ( ETR:ENR ) missed earnings with its latest second-quarter results, disappointing overly-optimistic...

Last week saw the newest quarterly earnings release from 1&1 AG ( ETR:1U1 ), an important milestone in the company's...

Siemens Healthineers (XTRA:SHL) received FDA clearance in the US for six new Artis interventional imaging systems featuring the Optiq AI imaging chain with deep-learning-based noise reduction. The company also secured renewed CDC HoSt-TT program certification for its Atellica IM Testosterone II assay, confirming its measurement accuracy in hormone testing. For readers tracking medical technology, Siemens Healthineers sits at the intersection of advanced imaging and diagnostic testing, two...

First quarter earnings set the tone for Jungheinrich Jungheinrich (XTRA:JUN3) opened the new financial year with first quarter results showing sales of €1,272 million and net income of €26.2 million, both lower than the same period a year earlier. See our latest analysis for Jungheinrich. The Q1 earnings update has come against a weak share price backdrop, with Jungheinrich’s stock down 29.1% on a year to date share price return and the 1 year total shareholder return also declining 25.7%...

Ströer SE & Co. KGaA ( ETR:SAX ) last week reported its latest quarterly results, which makes it a good time for...

The European market has recently experienced a volatile period, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings, though tempered by tariff threats from the U.S. In this environment, dividend stocks can be an attractive option for investors seeking steady income streams and potential portfolio enhancement, especially as they offer a measure of stability against market fluctuations.

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Last week, you might have seen that HOCHTIEF Aktiengesellschaft ( ETR:HOT ) released its first-quarter result to the...

Deutsche Lufthansa AG ( ETR:LHA ) just reported some strong earnings, and the market reacted accordingly with a healthy...

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...